ATE153665T1 - Tricyclische inhibitoren von gp ii b iii a rezeptoren - Google Patents
Tricyclische inhibitoren von gp ii b iii a rezeptorenInfo
- Publication number
- ATE153665T1 ATE153665T1 AT94923512T AT94923512T ATE153665T1 AT E153665 T1 ATE153665 T1 AT E153665T1 AT 94923512 T AT94923512 T AT 94923512T AT 94923512 T AT94923512 T AT 94923512T AT E153665 T1 ATE153665 T1 AT E153665T1
- Authority
- AT
- Austria
- Prior art keywords
- receptors
- iii
- platelet aggregation
- nonpeptidyl
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 abstract 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 108010022425 Platelet Glycoprotein GPIIb-IIIa Complex Proteins 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 229940127218 antiplatelet drug Drugs 0.000 abstract 1
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960000103 thrombolytic agent Drugs 0.000 abstract 1
- 230000002537 thrombolytic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/099,019 US5493020A (en) | 1993-07-29 | 1993-07-29 | Tricyclic inhibitors of the GPIIb IIIa receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE153665T1 true ATE153665T1 (de) | 1997-06-15 |
Family
ID=22272077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94923512T ATE153665T1 (de) | 1993-07-29 | 1994-07-15 | Tricyclische inhibitoren von gp ii b iii a rezeptoren |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US5493020A (de) |
| EP (1) | EP0708775B1 (de) |
| JP (1) | JP3929483B2 (de) |
| AT (1) | ATE153665T1 (de) |
| CA (1) | CA2166811C (de) |
| DE (1) | DE69403479T2 (de) |
| WO (1) | WO1995004057A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5693636A (en) * | 1991-06-28 | 1997-12-02 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5493020A (en) * | 1993-07-29 | 1996-02-20 | Genentech, Inc. | Tricyclic inhibitors of the GPIIb IIIa receptor |
| MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
| US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
| US20030125317A1 (en) | 1996-10-02 | 2003-07-03 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| US7109326B2 (en) | 1997-04-15 | 2006-09-19 | Genentech, Inc. | Halo-alkoxycarbonyl prodrugs |
| JP2001514253A (ja) * | 1997-09-04 | 2001-09-11 | スミスクライン・ビーチャム・コーポレイション | インテグリンレセプターアンタゴニスト |
| US6210904B1 (en) | 1997-10-14 | 2001-04-03 | Merck & Co., Inc. | Anticoagulant test |
| US6063584A (en) * | 1997-11-21 | 2000-05-16 | Merck & Co., Inc. | Anticoagulant test |
| JP2003504301A (ja) | 1998-04-01 | 2003-02-04 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | インテグリンアンタゴニスト |
| US6204282B1 (en) | 1998-11-30 | 2001-03-20 | Schering Corporation | Benzimidazole compounds that are vitronectin receptor antagonists |
| AU5826100A (en) * | 1999-07-13 | 2001-01-30 | F. Hoffmann-La Roche Ag | Benzazepinones and quinazolines |
| US6514964B1 (en) * | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| IL155035A0 (en) | 2000-09-27 | 2003-10-31 | Ajinomoto Kk | Benzodiazepine derivatives |
| EP1784390A2 (de) * | 2004-08-13 | 2007-05-16 | Amgen Inc. | Substituierte benzokondensierte heterozyklen |
| US9806270B2 (en) * | 2011-03-25 | 2017-10-31 | Udc Ireland Limited | 4H-imidazo[1,2-a]imidazoles for electronic applications |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5177071A (en) * | 1991-06-17 | 1993-01-05 | Merck & Co., Inc. | 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder |
| US5250679A (en) * | 1991-10-18 | 1993-10-05 | Genentech, Inc. | Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor |
| US5493020A (en) * | 1993-07-29 | 1996-02-20 | Genentech, Inc. | Tricyclic inhibitors of the GPIIb IIIa receptor |
-
1993
- 1993-07-29 US US08/099,019 patent/US5493020A/en not_active Expired - Fee Related
-
1994
- 1994-07-15 US US08/313,069 patent/US5705890A/en not_active Expired - Lifetime
- 1994-07-15 AT AT94923512T patent/ATE153665T1/de not_active IP Right Cessation
- 1994-07-15 DE DE69403479T patent/DE69403479T2/de not_active Expired - Fee Related
- 1994-07-15 CA CA002166811A patent/CA2166811C/en not_active Expired - Fee Related
- 1994-07-15 JP JP50585395A patent/JP3929483B2/ja not_active Expired - Fee Related
- 1994-07-15 WO PCT/US1994/007989 patent/WO1995004057A1/en not_active Ceased
- 1994-07-15 EP EP94923512A patent/EP0708775B1/de not_active Expired - Lifetime
-
1995
- 1995-05-08 US US08/438,143 patent/US5716951A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995004057A1 (en) | 1995-02-09 |
| DE69403479T2 (de) | 1998-01-22 |
| JPH09501158A (ja) | 1997-02-04 |
| JP3929483B2 (ja) | 2007-06-13 |
| CA2166811C (en) | 2007-04-24 |
| DE69403479D1 (de) | 1997-07-03 |
| EP0708775A1 (de) | 1996-05-01 |
| US5716951A (en) | 1998-02-10 |
| EP0708775B1 (de) | 1997-05-28 |
| CA2166811A1 (en) | 1995-02-09 |
| US5705890A (en) | 1998-01-06 |
| US5493020A (en) | 1996-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941222A0 (fi) | Ei-peptidyyli-tyyppisiä integriini-inhibiittoreita, jotka ovat spesifisiä GPIIbIIIa-reseptorin suhteen | |
| DE69403479D1 (de) | TRICYCLISCHE INHIBITOREN VON GP II b III a REZEPTOREN | |
| ES2126661T3 (es) | Pirazoles que tienen actividad antagonista de crf. | |
| NO933999L (no) | Fibrinogenreseptorantagonister | |
| ES2156934T3 (es) | Compuestos que presentan una potente actividad de antagonistas del calcio y de antioxidantes y su utilizacion como agentes citoprotectores. | |
| ECSP941135A (es) | Antagonistas triciclicos de vasopresina de benzacepina | |
| ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
| PE20020521A1 (es) | Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas | |
| ES2114882T3 (es) | Acidos hidroxialquilquinolinos insaturados como antagonistas de leucotrienos. | |
| ES2133807T3 (es) | Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas. | |
| UY23835A1 (es) | Procedimiento para la preparacion de compuesto de acilo | |
| MX9700557A (es) | Dihidrobenzofuranos. | |
| ES2163407T3 (es) | Derivados piperidinilos tiaciclicos. | |
| MX9702797A (es) | Agentes de enlace a cd23. | |
| ES2164088T3 (es) | Antagonistas de la sustancia p para el tratamiento de la emesis. | |
| AR010050A1 (es) | COMPUESTO TRICíCLICO SUSTITUIDO, COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE Y USO PARA FABRICAR UN MEDICAMENTO PARA INHIBIR SELECTIVAMENTE SPLA2 | |
| MX9306814A (es) | Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas. | |
| ES2079068T3 (es) | 2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas. | |
| ATE198202T1 (de) | Fibrinogen receptor antagonisten | |
| SE9302332D0 (sv) | New compounds | |
| MX9302951A (es) | Composicion farmaceutica para tratar la hiperproliferacion celular. | |
| ES2044100T3 (es) | Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos. | |
| PT1294732E (pt) | Compostos de rutenio (ii) para utilizacao na terapia do cancro | |
| ES2149193T3 (es) | Compuestos heterociclicos sustituidos con alquilo. | |
| DE69125175D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |